Mendelian Blog
Be the first to know more about our latest developments in the rare diseases field. Here you will find all the latest news about our tool, its development, and relevant information about rare diseases and the people involved in them.
The Role of the GP in Rare Disease Diagnosis and Care
With the average time it takes to receive a rare disease diagnosis currently over 5.6 years the role of Primary Healthcare professionals in the rare disease diagnostic journey is vital
Read more
Rare diseases 101 - Systemic Amyloidosis
Amyloidosis is a rare disease, caused when certain proteins misfold causing abnormal deposition and accumulation of amyloid fibrils in the tissue, systems and organs of the body. It may be systemic or localised.
Read more
We are part of Start Alliance Berlin Digital Health
We have been chosen to be part of Start Alliance Berlin Digital Health. Everything is settled and we are looking forward to joining the program. This will be two exciting weeks, with a final Demo Day on November 22nd!
Read more
Mendelian at Pitch@Palace
42 Entrepreneurs delivered a 3 minute Pitch to an Audience of Supporters and Elevators. 12 Entrepreneurs were selected for a 3 minute Pitch and the remaining Entrepreneurs will Pitch for 30 seconds at Buckingham Palace on 8 November, 2018. We have…
Read more
We are part of KQ Labs
We have been chosen to be part of KQ Labs. KQ Labs is an intensive accelerator programme offered to high growth potential startup teams in the area of data-driven biomedical science.
Read more
Orphan Drugs – Meeting Global Unmet Health Needs
Developing cures for rare diseases is fraught with immense challenges for pharmaceutical companies committed to curing rare. Here we give a brief overview of this industry.
Read more
Mendelian at The rare disease challenge meeting
We will be part of RxRE 2018, an innovative two-day event in London organised by Pfizer, to help improve the lives of people with rare diseases and accelerate the time it takes for them to get an accurate diagnosis.
Read more
Rare Diseases 101 – Fabry Disease
We have compiled the latest information about Frabys Disease symptoms, diagnosis, treatments, related organizations, and many more for our disease education blog series.
Read more
Why Diagnosis Matter
Living with an unnamed or undiagnosed condition can be daunting. Learn how to get the right diagnosis using the most up to date tools available.
Read more
Difficulties of Rare Disease Diagnosis
Learn why getting the correct diagnosis is often the first major hurdle to tackle in the Diagnosis Odyssey, and discover why as many as 1 in 17 (7%) people are affected by a rare or orphan diseases at some stage in their lives.
Read more
Tips for undiagnosed rare disease patients
Whether you or your child are suffering from a rare or undiagnosed condition, there are always options to explore. We’ve come up with a few to tips to help ease your worry and get you closer to the truth about your health.
Read more
Security and Privacy while Handling Health Information
Privacy is usually confused with confidentiality. Learn about the importance to guarantee patient’s privacy and security and how we care about it on Mendelian.
Read more
Tech companies CAN work with the NHS
In 2016, DeepMind announced that they would work on 1.6m patient records from the Royal Free NHS Trust in London. The media reacted mostly with suspicion and outrage
Read more
Clinical Diagnosis for Computer Scientists: Machines reading patient records
Experienced doctors are better doctors. We’d all fight over that doctor that has seen a hundred cases like yours last week. Alas, most doctors haven’t. Thankfully they are routinely recording their experiences in electronic health records. The dream…
Read more
Mendelian among the most innovative companies of the year by "El Pais".
The eleventh edition of the awards of the dean of the economic press recognizes leading initiatives.The awards are presented on 5 July in the Repsol auditorium in Madrid
Read more
Mendelian and Pfizer Agreement
For more than two decades, the biomedical company Pfizer has been working in the research and development of treatments to respond to the unmet medical needs of people living with rare diseases
Read more2 of 2